Clinically important differences in health status for patients with heart disease: an expert consensus panel report
Related Experiment Video
Updated: Aug 24, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Kathleen W Wyrwich1, John A Spertus, Kurt Kroenke
1Department of Research Methodology, Saint Louis University, St Louis, MO 63103, USA. wyrwichk@slu.edu
Insights
Clinically Important Difference (CID) standards were developed for the Chronic Heart Failure Questionnaire (CHQ) and SF-36 in heart disease patients. These standards aid in interpreting health status changes for better clinical decision-making.
Area of Science:
- Cardiology
- Health Outcomes Research
- Clinical Practice Guidelines
Background:
- Clinically Important Difference (CID) standards are crucial for interpreting health status changes in patients with chronic heart conditions.
- Existing standards for the Chronic Heart Failure Questionnaire (CHQ) primarily focused on patient-perceived changes.
- No established CID standards existed for the Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36) in heart disease populations.
Framework:
- Modification of the RAND Appropriateness Method was employed.
- A 9-member consensus panel of physicians with expertise in CHQ and SF-36 use in heart disease patients was assembled.
- The panel guided the development of CID standards through consensus.
Implementation:
- The expert panel achieved consensus on small, medium, and large clinically relevant score changes for both the CHQ and SF-36.
- Consensus was based on the panel's clinical experience and a review of relevant literature.
- The developed CID standards were found to be slightly higher than previously established minimal important difference standards for the CHQ.
Implications:
- The established CID standards offer a valuable tool for assessing the clinical significance of health status changes.
- These standards enhance physicians' capacity for informed decision-making in clinical practice.
- Routine clinical health status assessments can be better utilized to determine patient benefit.
Background:
The purpose of the study was to develop clinically important difference (CID) standards for patients with coronary artery disease and congestive heart failure that identify small, moderate, and large intraindividual changes with time in a modified version of the Chronic Heart Failure Questionnaire (CHQ) and the Medical Outcomes Study Short-Form 36-Item Health Survey (SF-36, version 2). Prior work in ascertaining important difference standards for the CHQ have centered on patient-perceived changes. No important difference standards for the SF-36 have been published for patients with heart disease. This development of CIDs would facilitate the use of health status measures in daily clinical decision-making.
Methods:
We used a modification of the RAND Appropriateness Method to assemble and guide a 9-member consensus panel of physicians with substantial experience in using the CHQ or the SF-36 among patients with heart disease.
Results:
On the basis of their own experience using these measures and an extensive review of articles describing the development and use of these instruments, the expert panel achieved consensus on small, medium, and large clinically relevant changes in scores for the CHQ and SF-36. The CID standards established by this panel were slightly higher than the minimal important difference standards previously established for the CHQ using patient-perceived changes.
Conclusions:
The CID standards established by this expert panel provide an important and useful tool for determining whether routine clinical health status assessments will benefit patients and enhance physicians' decision-making capacity in clinical settings.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Rheumatic Heart Disease III: Medical Management